Status:
TERMINATED
FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units
Lead Sponsor:
Kyungmin Huh
Conditions:
Pneumonia, Ventilator-Associated
Pneumonia, Hospital Acquired
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Microbiologic diagnosis of pneumonia is often limited by a long turnaround time of cultures. This randomized trial aims to evaluate the impact of BioFire FilmArray Pneumonia panel on (1) the proportio...
Detailed Description
The study subjects are adults treated for HAP/VAP in ICU, who should be enrolled within 24 hrs since the first administration of antibiotics. Informed consent are obtained from the subjects or their l...
Eligibility Criteria
Inclusion
- Aged 19 years or older
- Diagnosed with hospital-acquired or ventilator-associated pneumonia and being treated in an intensive care unit
- Patient or his/her legal proxy agrees to participate and is able to provide informed consent
Exclusion
- Has been treated with antibiotic for HAP/VAP for 24 hr or longer
- Requires antibiotic treatment for indications other than HAP/VAP
- Bacteria has been isolated from respiratory specimens within 7 days prior to screening
- Immunocompromised host whose major differential diagnosis includes Pneumocystis jirovecii or cytomegalovirus pneumonia
- Expected to die within 2 days since screening due to underlying disease
- Has an advance directive against mechanical ventilation or cardiopulmonary resuscitation
- Does not want to participate or unable to provide consent
- Determined to be unfit by the study investigator
Key Trial Info
Start Date :
July 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2024
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05214716
Start Date
July 12 2022
End Date
March 21 2024
Last Update
April 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351